Rocket


Overview
Financials
News + Filings
Key Docs
Charts
Ownership
Insiders





Income Statement
Balance Sheet
Cash Flow Statement

Common Size IS
Op Efficiency
Credit Analysis

Loxo Oncology, Inc. (LOXO)

Cash Flow Statement

Standardized | As Reported Annual | Quarterly | TTM
 
In millions, except per share itemsDec-31-17Dec-31-16Dec-31-15Dec-31-14Dec-31-13
   10-K10-K10-K10-K10-K
Net income  -148.9-72.4-35.9-20.70.0
Depreciation and amortization   [+]0.20.60.40.0 
Stock-based compensation  19.48.06.23.0 
Change in working capital   [+]237.012.5-0.9-0.1 
Other operating activities     0.0 
Cash from operations  107.8-51.3-30.2-17.70.0
   
Capital expenditures  -0.8-0.2-0.10.00.0
Purchases of short-term investments, net  -373.4-26.3-17.1-69.1 
Cash from investing  -374.2-26.5-17.2-69.10.0
   
Issuance of common stock, net  375.338.771.374.2 
Option exercises  2.71.30.30.2 
Financing costs     -1.8 
Other cash from financing  5.52.50.639.9 
Cash from financing  378.040.071.6115.70.0
   
Free cash flow  107.0-51.6-30.3-17.70.0
        Per share (diluted)  $3.82($2.47)($1.79)($2.61) 

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy